Function
Locations
Deficiency = metachromatic leukodystrophy (MLD).
Complex sphingolipids are catabolised in the lysosome by a branched cascade of soluble acid hydrolases that strip the head group one residue at a time and converge on ceramide, which is finally hydrolysed to sphingosine. Sphingomyelin is cleaved by acid sphingomyelinase (SMPD1) directly to ceramide; glucosylceramide is cleaved by acid beta-glucocerebrosidase (GBA); galactosylceramide by galactocerebrosidase (GALC); and sulfatide is first desulfated by arylsulfatase A (ARSA) to galactosylceramide, which GALC then degrades. Gangliosides feed in from above (GM1 via acid beta-galactosidase GLB1, modelled here as the ganglioside entry step; GM2 via beta-hexosaminidase A + the GM2-activator and globosides via GLA/HEXA-HEXB, not yet modelled here), ultimately yielding glucosylceramide; GLB1 also hydrolyses lactosylceramide to glucosylceramide. The convergent final step is acid ceramidase (ASAH1), which hydrolyses ceramide to sphingosine and a free fatty acid. Because the substrates are membrane-embedded lipids, most of these hydrolases require small non-enzymatic lipid-presenting cofactors: the four saposins (A, B, C, D) generated from prosaposin (PSAP) activate GALC, ARSA/GLB1, GBA and ASAH1 respectively, and the GM2-activator (GM2A) presents GM2 ganglioside to beta-hexosaminidase A. Each hydrolase and cofactor defines a sphingolipidosis: metachromatic leukodystrophy (ARSA), Krabbe disease (GALC), Gaucher disease (GBA), Niemann-Pick A/B (SMPD1), Farber disease / SMA-PME (ASAH1), the AB-variant GM2 gangliosidosis (GM2A) and combined saposin deficiency (PSAP).
All recommended fields populated.
✗ none found
No MODULE:glycosphingolipid_lysosomal_degradation deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
8 gene-function check(s) reflected in core functions · 0 conflict(s) · 8 evidence or coverage gap(s) (16 comparison(s))
Retained noncore functions are reported separately; they do not require promotion to core functions. Support from representative genes does not establish conservation across the whole family. Missing reviews or identifiers leave a claim unverified.
| Annoton | Participant | Function | Assessment |
|---|---|---|---|
| arsa_activity | ARSA (human) UniProtKB:P15289 Family Representative |
cerebroside-sulfatase activity GO:0004098 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| galc_activity | GALC (human) UniProtKB:P54803 Family Representative |
galactosylceramidase activity GO:0004336 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| gba_activity | GBA (human) UniProtKB:P04062 Family Representative |
glucosylceramidase activity GO:0004348 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| smpd1_activity | SMPD1 (human) UniProtKB:P17405 Family Representative |
sphingomyelin phosphodiesterase activity GO:0004767 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| asah1_activity | ASAH1 (human) UniProtKB:Q13510 Family Representative |
N-acylsphingosine amidohydrolase activity GO:0017040 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| psap_activity | PSAP (human) UniProtKB:P07602 Family Representative |
sphingolipid activator protein activity GO:0030290 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| gm2a_activity | GM2A (human) UniProtKB:P17900 Family Representative |
lipid chaperone activity GO:7770043 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| glb1_gsl_activity | GLB1 (human) UniProtKB:P16278 Family Representative |
beta-galactosidase activity GO:0004565 |
Core Supported
The GO molecular function is reflected in core_functions (exact term or a reviewed subclass). |
| arsa_activity | Sulfatase family (ARSA) PANTHER:PTHR42693 Family |
cerebroside-sulfatase activity GO:0004098 |
Family Review Missing
No supported structured family review is available for PANTHER:PTHR42693. |
| galc_activity | Glycosyl hydrolase 59 family (GALC) PANTHER:PTHR15172 Family |
galactosylceramidase activity GO:0004336 |
Family Review Missing
No supported structured family review is available for PANTHER:PTHR15172. |
| gba_activity | Glycosyl hydrolase 30 family (GBA) PANTHER:PTHR11069 Family |
glucosylceramidase activity GO:0004348 |
Family Review Missing
No supported structured family review is available for PANTHER:PTHR11069. |
| smpd1_activity | Acid sphingomyelinase family (SMPD1) PANTHER:PTHR10340 Family |
sphingomyelin phosphodiesterase activity GO:0004767 |
Family Function Unreviewed
The family review has no applicable adjudication supporting or excluding GO:0004767. |
| asah1_activity | Acid ceramidase / N-acylethanolamine-hydrolase family (ASAH1) PANTHER:PTHR28583 Family |
N-acylsphingosine amidohydrolase activity GO:0017040 |
Family Review Missing
No supported structured family review is available for PANTHER:PTHR28583. |
| psap_activity | Saposin / prosaposin family (PSAP) PANTHER:PTHR11480 Family |
sphingolipid activator protein activity GO:0030290 |
Family Review Missing
No supported structured family review is available for PANTHER:PTHR11480. |
| gm2a_activity | GM2 activator protein family (GM2A) PANTHER:PTHR17357 Family |
lipid chaperone activity GO:7770043 |
Family Review Missing
No supported structured family review is available for PANTHER:PTHR17357. |
| glb1_gsl_activity | Glycosyl hydrolase 35 family (GLB1) PANTHER:PTHR23421 Family |
beta-galactosidase activity GO:0004565 |
Family Review Missing
No supported structured family review is available for PANTHER:PTHR23421. |
5 complete review(s) · 1 with deep research · 0 missing review · 7 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| ARSA P15289 | ✓ | 30/41 | ✗ |
| ASAH1 Q13510 | ✓ | ✓ | ✗ |
| GALC P54803 | ✓ | ✓ | ✗ |
| GBA1 P04062 | ✓ | 95/96 | ✗ |
| GLB1 P16278 | ✓ | 58/63 | ✓ |
| GM2A P17900 | ✓ | ✓ | ✗ |
| PSAP P07602 | ✓ | ✓ | ✗ |
| SMPD1 P17405 | ✓ | ✓ | ✗ |
Lysosomal glycosphingolipid/sphingolipid degradation, grounded to the human enzymes ARSA (UniProtKB:P15289, GO:0004098, EC 3.1.6.8), GALC (P54803, GO:0004336, EC 3.2.1.46), GBA (P04062, GO:0004348, EC 3.2.1.45), SMPD1 (P17405, GO:0004767, EC 3.1.4.12) and ASAH1 (Q13510, GO:0017040, EC 3.5.1.23), plus the non-catalytic lipid-presenting cofactors PSAP (P07602, GO:0030290 sphingolipid activator protein activity; precursor of saposins A-D) and GM2A (P17900, GO:7770043 lipid chaperone activity; GM2 activator). GO molecular-function/BP/location terms were taken from the completed human gene reviews and verified against the local go.db; Reactome reaction ids/titles were verified against the local reactome cache. Each step uses a PANTHER family selector; the cofactor node groups PSAP and GM2A. The pathway is a convergent tree: sphingomyelin (SMPD1), glucosylceramide (GBA) and galactosylceramide (GALC; fed by ARSA desulfation of sulfatide) all yield ceramide, which ASAH1 hydrolyses to sphingosine — the exit point recycled by the salvage pathway. Gangliosides enter from above via GLB1 (GM1 to GM2; added as step 7, which also covers GLB1 hydrolysis of lactosylceramide to glucosylceramide), HEXA/HEXB + GM2A (GM2) and GLA (globosides); HEXA/HEXB are modelled in the keratan/chondroitin-sulfate module and GLA is not yet modelled. Because the substrates are membrane lipids, the hydrolases depend on the saposins (SapA->GALC, SapB->ARSA/GLB1, SapC->GBA, SapD->ASAH1) and GM2A (->HexA), modelled here as an activator node that positively regulates the hydrolases. Disorders (the sphingolipidoses): metachromatic leukodystrophy (ARSA), Krabbe (GALC), Gaucher (GBA), Niemann-Pick A/B (SMPD1), Farber / SMA-PME (ASAH1), AB-variant GM2 gangliosidosis (GM2A) and combined saposin deficiency (PSAP).
Deficiency = metachromatic leukodystrophy (MLD).
Deficiency = Krabbe disease (globoid cell leukodystrophy).
Deficiency = Gaucher disease.
Deficiency = Niemann-Pick disease types A and B.
Convergent final step of glycosphingolipid degradation. Deficiency = Farber disease / SMA-PME.
Non-catalytic saposin cofactors; deficiency phenocopies the cognate enzyme diseases.
Non-catalytic GM2-presenting cofactor for beta-hexosaminidase A.
Entry of GM1 ganglioside into the degradation tree; the same enzyme also removes the terminal galactose of keratan sulfate (modelled in keratan_chondroitin_sulfate_lysosomal_degradation). Deficiency = GM1 gangliosidosis (allelic with MPS IVB).